Ashfaqul Alam

Ashfaqul Alam

Auto-generated profile, based on publicly available information

Ashfaqul Alam

Department of Microbiology, Immunology and Molecular Genetics, College of Medicine, University of Kentucky

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
CCChun Chen
Chun Chen
EAEun Hee Ahn
Eun Hee Ahn
SKSeong Su Kang
Seong Su Kang
XLXia Liu
Xia Liu
AAAshfaqul Alam
Ashfaqul Alam
KYKeqiang Ye
Keqiang Ye
The gut-brain axis is bidirectional, and gut microbiota influence brain disorders including Alzheimer’s disease (AD). CCAAT/enhancer binding protein β/asparagine endopeptidase (C/EBPβ/AEP) signaling spatiotemporally mediates AD pathologies in the brain via cleaving both β-amyloid precursor protein and Tau. We show that gut dysbiosis occurs in 5xFAD mice, and is associated with escalation of the C/EBPβ/AEP pathway in the gut with age. Unlike that of aged wild-type mice, the microbiota of aged 3xTg mice accelerate AD pathology in young 3xTg mice, accompanied by active C/EBPβ/AEP signaling in the brain. Antibiotic treatment diminishes this signaling and attenuates amyloidogenic processes in 5xFAD, improving cognitive functions. The prebiotic R13 inhibits this pathway and suppresses amyloid aggregates in the gut. R13-induced Lactobacillus salivarius antagonizes the C/EBPβ/AEP axis, mitigating gut leakage and oxidative stress. Our findings support the hypothesis that C/EBPβ/AEP signaling is activated by gut dysbiosis, implicated in AD pathologies in the gut.

21 December 2022 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
EAEun Hee Ahn
Eun Hee Ahn
XLXia Liu
Xia Liu
AAAshfaqul M. Alam
Ashfaqul M. Alam
SKSeong Su Kang
Seong Su Kang
KYKeqiang Ye
Keqiang Ye

10 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CSCaitlyn B. Smith
Caitlyn B. Smith
AGAngela Gao
Angela Gao
PBPaloma Bravo
Paloma Bravo
AAAshfaqul Alam
Ashfaqul Alam
The interactions between Campylobacter jejuni , a critical foodborne cause of gastroenteritis, and the intestinal microbiota during infection are not completely understood. The crosstalk between C. jejuni and its host is impacted by the gut microbiota through mechanisms of competitive exclusion, microbial metabolites, or immune response. To investigate the role of gut microbiota on C. jejuni pathogenesis, we examined campylobacteriosis in the IL10KO mouse model, which was characterized by an increase in the relative abundance of intestinal proteobacteria, E. coli , and inflammatory cytokines during C. jejuni infection. We also found a significantly increased abundance of microbial metabolite Trimethylamine N-Oxide (TMAO) in the colonic lumens of IL10KO mice. We further investigated the effects of TMAO on C. jejuni pathogenesis. We determined that C. jejuni senses TMAO as a chemoattractant and the administration of TMAO promotes C. jejuni invasion into Caco-2 monolayers. TMAO also increased the transmigration of C. jejuni across polarized monolayers of Caco-2 cells, decreased TEER, and increased C. jejuni -mediated intestinal barrier damage. Interestingly, TMAO treatment and presence during C. jejuni infection of Caco-2 cells synergistically caused an increased inflammatory cytokine expression, specifically IL-1β and IL-8. These results establish that C. jejuni utilizes microbial metabolite TMAO for increased virulence during infection.